Information:
Fel:
ID
33980
Beskrivning
A Study of Tarceva (Erlotinib) or Placebo in Combination With Platinum-Based Therapy as First Line Treatment in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00883779
Länk
https://clinicaltrials.gov/show/NCT00883779
Nyckelord
Versioner (1)
- 2019-01-09 2019-01-09 -
Rättsinnehavare
See clinicaltrials.gov
Uppladdad den
9 januari 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Non-Squamous Non-Small Cell Lung Cancer NCT00883779
Eligibility Non-Squamous Non-Small Cell Lung Cancer NCT00883779
- StudyEvent: Eligibility
Similar models
Eligibility Non-Squamous Non-Small Cell Lung Cancer NCT00883779
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Adult | Age
Item
adult patients, >=18 years of age;
boolean
C0001675 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0001779 (UMLS CUI [2])
Non-Small Cell Lung Carcinoma Advanced TNM clinical staging
Item
advanced (stage iiib/iv)non-small cell lung cancer;
boolean
C0007131 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C3258246 (UMLS CUI [1,3])
C0205179 (UMLS CUI [1,2])
C3258246 (UMLS CUI [1,3])
Measurable Disease
Item
measurable disease;
boolean
C1513041 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status 0 or 1.
boolean
C1520224 (UMLS CUI [1])
Exposure to Pharmaceutical Preparations Targeting Epidermal Growth Factor Receptor
Item
prior exposure to agents directed at the her axis;
boolean
C0332157 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C1521840 (UMLS CUI [1,3])
C0034802 (UMLS CUI [1,4])
C0013227 (UMLS CUI [1,2])
C1521840 (UMLS CUI [1,3])
C0034802 (UMLS CUI [1,4])
Prior Chemotherapy | Cancer treatment Systemic | Status post Advanced disease
Item
prior chemotherapy or systemic anti-tumor therapy after advanced disease;
boolean
C1514457 (UMLS CUI [1])
C0920425 (UMLS CUI [2,1])
C0205373 (UMLS CUI [2,2])
C0231290 (UMLS CUI [3,1])
C0679246 (UMLS CUI [3,2])
C0920425 (UMLS CUI [2,1])
C0205373 (UMLS CUI [2,2])
C0231290 (UMLS CUI [3,1])
C0679246 (UMLS CUI [3,2])
Systemic disease Unstable
Item
unstable systemic disease;
boolean
C0442893 (UMLS CUI [1,1])
C0443343 (UMLS CUI [1,2])
C0443343 (UMLS CUI [1,2])
Cancer Other | Exception Basal cell carcinoma Cured | Exception Carcinoma in situ of uterine cervix Cured
Item
any other malignancy within last 5 years, except cured basal cell cancer of skin or cured cancer in situ of cervix;
boolean
C1707251 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0007117 (UMLS CUI [2,2])
C1880198 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C0851140 (UMLS CUI [3,2])
C1880198 (UMLS CUI [3,3])
C1705847 (UMLS CUI [2,1])
C0007117 (UMLS CUI [2,2])
C1880198 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C0851140 (UMLS CUI [3,2])
C1880198 (UMLS CUI [3,3])
Metastatic malignant neoplasm to brain | Compression of spinal cord
Item
brain metastasis or spinal cord compression.
boolean
C0220650 (UMLS CUI [1])
C0037926 (UMLS CUI [2])
C0037926 (UMLS CUI [2])